Ava, a medical technology company focused on innovations in women's reproductive health, yesterday announced their expansion into Asia with the launch of an office in Hong Kong. The company has also unveiled an improved and updated version of its popular Ava fertility tracker, along with a host of new premium services available to US users, including a one-year pregnancy guarantee and access to...
Ava, the San Francisco- and Zurich-based maker of a connected menstrual cycle tracking bracelet, today announced the closure of a $30 million series B funding round. The funding was led by the company’s existing investors — which include Polytech Ecosystem Ventures, Blue Ocean Ventures, Global Sources, ZKB, and Swisscom — with new investors btov and SVC also participating.
According to...
Preliminary results from a large clinical trial suggest that Ava Health’s fertility detecting wearable could someday be used to detect pregnancy. The research, conducted at the University of Zurich in Switzerland, was presented this week at the annual conference of the American Society of Reproductive Medicine.
“We started Ava with the intention of looking at physiological parameters to detect...
